Table 2

Baseline biochemical profile of the five patients who developed Graves’s disease following vaccination against SARS-CoV-2

InvestigationPatient 17Patient 27Patient 38Patient 48Patient 5Reference range
40-year-old woman28-year-old woman71-year-old woman46-year-old man71-year-old woman (case presentation)
Thyroid Stimulating Hormone<0.001<0.001<0.020.35–2.00 µ(IU)/mL
Free T43.571.843.561.637.20.9–1.7 ng/dL
Total T325121611.100.8–2.8 ng/mL
Free T310.–4.4 pg/mL
Anti-TSH receptor Antibodies16.565.854.22.90–1.75 UI/L
Thyroid stimulating immunoglobulin380347<140% baseline
  • – shows lab value was not obtained or no value was available per patient records.